ALNY

NASDAQStock

Alnylam Pharmaceuticals, Inc.

$313.45-3.77 (-1.19%)

52-Week Range

$224.32
$491.22

Key Stats

Market Cap

41.6B

P/E Ratio

155.95

Dividend Yield

Beta

0.38

Volume

526.0K

Avg Volume

1.5M

Performance

1M

+2.84%

3M

-18.97%

6M

-31.21%

YTD

-20.73%

1Y

+31.22%

3Y

+70.78%

5Y

+117.10%

Price Chart

ETF Exposure

ALNY is held by 460 ETFs

ETFFund NameWeight
VGWL.DEVanguard FTSE All-World UCITS ETF (USD) Distributing0.04%
VWCE.DEVanguard FTSE All-World UCITS ETF (USD) Accumulating0.04%
VWRL.SWVanguard FTSE All-World UCITS ETF (USD) Distributing0.04%
CBUH.DEiShares MSCI World Momentum Factor Advanced UCITS ETF0.04%
NZACState Street SPDR MSCI ACWI Climate Paris Aligned ETF0.04%
VTVanguard Total World Stock ETF0.04%
EEWG.LiShares MSCI World CTB Enhanced ESG UCITS ETF0.04%
EMND.DEiShares MSCI World CTB Enhanced ESG UCITS ETF0.04%
SPUTInnovator Equity Premium Income – Daily PutWrite ETF0.04%
MAGU.ASiShares Growth Portfolio UCITS ETF0.03%
VEQT.TOVanguard All-Equity ETF Portfolio0.03%
XEQT.TOiShares Core Equity ETF Portfolio0.03%
VALTETFMG Sit Ultra Short ETF0.03%
EAOAiShares ESG Aware 80/20 Aggressive Allocation ETF0.02%
SPGMState Street SPDR Portfolio MSCI Global Stock Market ETF0.02%
JREG.DEJPMorgan ETFs (Ireland) ICAV - Global Research Enhanced Index Equity Active UCITS ETF0.02%
JREG.LJPMorgan ETFs (Ireland) ICAV - Global Research Enhanced Index Equity Active UCITS ETF0.02%
EPSWisdomTree U.S. LargeCap Fund0.02%
AVLCAvantis U.S. Large Cap Equity ETF0.02%
DXUVDimensional - US Vector Equity ETF0.02%
EAORiShares ESG Aware 60/40 Balanced Allocation ETF0.02%
ITDGiShares LifePath Target Date 2055 ETF0.02%
ITDHiShares LifePath Target Date 2060 ETF0.02%
ITDIiShares LifePath Target Date 2065 ETF0.02%
ITDJiShares LifePath Target Date 2070 ETF0.02%
ITDFiShares LifePath Target Date 2050 ETF0.02%
ITDEiShares LifePath Target Date 2045 ETF0.01%
SILXETFMG Prime 2x Daily Junior Silver Miners ETF0.01%
ONEOState Street SPDR Russell 1000 Momentum Focus ETF0.01%
CPIIQ Real Return ETF0.01%
ITDDiShares LifePath Target Date 2040 ETF0.01%
EAOMiShares ESG Aware 40/60 Moderate Allocation ETF0.01%
VCNS.TOVanguard Conservative ETF Portfolio0.01%
ITDCiShares LifePath Target Date 2035 ETF0.01%
AVTMAvantis Total Equity Markets ETF 10.01%
PRFInvesco RAFI US 1000 ETF0.01%
EAOKiShares ESG Aware 30/70 Conservative Allocation ETF0.01%
IALTiShares Systematic Alternatives Active ETF0.01%
ITDBiShares LifePath Target Date 2030 ETF0.01%
LSLTPacer Salt Low truBeta US Market ETF0.01%
SLTPacer Salt High truBeta US Market ETF0.01%
TRPLPacer Metaurus US Large Cap Dividend Multiplier 300 ETF0.01%
VETSPacer Military Times Best Employers ETF0.01%
VIRSPacer BioThreat Strategy ETF0.01%
HSUD.MIHSBC USA Sustainable Equity UCITS ETF0.01%
INROiShares U.S. Industry Rotation Active ETF0.01%
IRTRiShares LifePath Retirement ETF0.01%
FGLR.LFidelity Global Equity Research Enhanced UCITS ETF ACC-USD0.01%
FGLS.LFidelity Global Equity Research Enhanced UCITS ETF ACC-USD0.01%
OMFLInvesco Russell 1000 Dynamic Multifactor ETF0.01%
PreviousPage 9 of 10Next

About ALNY ETF Exposure

Alnylam Pharmaceuticals, Inc. (ALNY) is held by 460 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 41.6B, ALNY is a widely held institutional stock. The stock currently trades at $313.45. Investors can gain exposure to ALNY through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold ALNY, sorted by portfolio weight.